Darya-Varia Laboratoria Tbk Market Cap ($103.04 Million)
Market Cap & Net Worth: Darya-Varia Laboratoria Tbk (DVLA)
Darya-Varia Laboratoria Tbk market cap. Darya-Varia Laboratoria Tbk (JK:DVLA) has a market capitalization of $103.04 Million (Rp1.76 Trillion) as of November 1, 2026. Listed on the JK stock exchange, this Indonesia-based company holds position #18892 globally and #301 in its home market, demonstrating a -0.63% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Darya-Varia Laboratoria Tbk's stock price Rp1570.00 by its total outstanding shares 1120000000 (1.12 Billion). Also see Darya-Varia Laboratoria Tbk (DVLA) cash flow conversion for how efficiently the company converts equity into cash flow.
Darya-Varia Laboratoria Tbk Market Cap History (2015–2026)
Darya-Varia Laboratoria Tbk market cap history from 2015 to 2026. Data shows growth from $54.76 Million to $103.04 Million (5.15% CAGR). Check DVLA share price today for real-time trading data and today's change.
Index Memberships
Darya-Varia Laboratoria Tbk is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Jakarta Stock Exchange Composite Index
JKSE
|
$412.24 Billion | 0.02% | #292 of 864 |
Weight: Darya-Varia Laboratoria Tbk's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Darya-Varia Laboratoria Tbk Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Darya-Varia Laboratoria Tbk's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore DVLA shareholders equity momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.00x
Darya-Varia Laboratoria Tbk's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.00x
Darya-Varia Laboratoria Tbk's market cap is 0.00 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $54.76 Million | $1.31 Trillion | $107.89 Billion | 0.00x | 0.00x |
| 2016 | $75.73 Million | $1.45 Trillion | $152.08 Billion | 0.00x | 0.00x |
| 2017 | $88.78 Million | $1.58 Trillion | $162.25 Billion | 0.00x | 0.00x |
| 2018 | $92.92 Million | $1.70 Trillion | $200.65 Billion | 0.00x | 0.00x |
| 2019 | $113.20 Million | $1.81 Trillion | $221.78 Billion | 0.00x | 0.00x |
| 2020 | $127.43 Million | $1.83 Trillion | $162.07 Billion | 0.00x | 0.00x |
| 2021 | $151.47 Million | $1.90 Trillion | $146.51 Billion | 0.00x | 0.00x |
| 2022 | $136.57 Million | $1.92 Trillion | $149.38 Billion | 0.00x | 0.00x |
| 2023 | $102.40 Million | $1.89 Trillion | $146.34 Billion | 0.00x | 0.00x |
| 2024 | $105.00 Million | $2.09 Trillion | $156.15 Billion | 0.00x | 0.00x |
Competitor Companies of DVLA by Market Capitalization
Companies near Darya-Varia Laboratoria Tbk in the global market cap rankings as of November 1, 2026. Also see Darya-Varia Laboratoria Tbk (DVLA) total assets for a full breakdown of the balance sheet.
Key companies related to Darya-Varia Laboratoria Tbk by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #511 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #535 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #593 globally with a market cap of $45.23 Billion USD ( CN¥309.13 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #511 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #535 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.62 |
| #593 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.23 Billion | CN¥48.46 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.30 |
Market Capitalization of Darya-Varia Laboratoria Tbk (2015–2026)
Market capitalization of Darya-Varia Laboratoria Tbk from 2015 to today. Between 2015 and today, Darya-Varia Laboratoria Tbk's market cap moved from $54.76 Million to $ 103.04 Million, with a yearly change of 5.15%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rp103.04 Million | -4.85% |
| 2025 | Rp108.29 Million | +3.12% |
| 2024 | Rp105.00 Million | +2.54% |
| 2023 | Rp102.40 Million | -25.02% |
| 2022 | Rp136.57 Million | -9.84% |
| 2021 | Rp151.47 Million | +18.87% |
| 2020 | Rp127.43 Million | +12.57% |
| 2019 | Rp113.20 Million | +21.82% |
| 2018 | Rp92.92 Million | +4.66% |
| 2017 | Rp88.78 Million | +17.24% |
| 2016 | Rp75.73 Million | +38.28% |
| 2015 | Rp54.76 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Darya-Varia Laboratoria Tbk was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $103.04 Million USD |
| MoneyControl | $103.04 Million USD |
| MarketWatch | $103.04 Million USD |
| marketcap.company | $103.04 Million USD |
| Reuters | $103.04 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Darya-Varia Laboratoria Tbk
PT Darya-Varia Laboratoria Tbk manufactures and trades pharmaceutical products and cosmetics in Indonesia. It operates in four segments: Prescription Drugs, Consumer Health Products, Export and Toll Manufacturing Services, and Services. The company offers prescription products in various areas of cardiology, analgesics, gastro-hepatology, dermamedic, somatic, cough and cold, antibiotic, women hea… Read more